August 3, 2017 09:41 AM EDTUpdated 12:14 PM
Pharma

FDA of­fers an­oth­er speedy can­cer drug OK, ap­prov­ing Jazz’s Vyx­eos for acute myeloid leukemia

Shehla Shakoor

Managing Director

In just the lat­est case of a can­cer drug sped along by the FDA, Jazz Phar­ma­ceu­ti­cals $JAZZ to­day won ap­proval for Vyx­eos (CPX-351) as …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times